Research

Research that saves lives, and makes them longer and kinder.

Cancer is the number one cause of death by disease among children. We raise funds for research that leads to more effective and less toxic treatments for kids.

$425K+raised for pediatric cancer research since 2023
Memorial Sloan Kettering Cancer Center

Our research partner

Dr. Michael Ortiz at Memorial Sloan Kettering Cancer Center

The people of Memorial Sloan Kettering are united by a singular mission: ending cancer for life. Dr. Ortiz’s research focuses on rare pediatric tumors and cancers, the kind that too often fall through the gaps in research funding.

Dr. Ortiz led Alessia’s care when she was diagnosed with Wilms tumor in 2021. Today, all proceeds from Navis Foundation events support his work.

Why it matters

Kids deserve the same cutting-edge care as adults.

  • 40+

    children in the U.S. are expected to be diagnosed with cancer every day. About 1 in 266 will be diagnosed before their 20th birthday.

  • 95%

    of childhood cancer survivors have a chronic health condition by age 45, often linked to the treatments that saved them.

  • 4%

    of the National Cancer Institute’s budget has historically gone to research focused on childhood cancer.

Sources: American Cancer Society, Cancer Statistics 2026 (opens in a new tab) and National Cancer Institute (opens in a new tab) and NCI Wilms tumor treatment (PDQ) (opens in a new tab) and St. Jude Lifetime Cohort Study (opens in a new tab) and Children’s Cancer Cause (opens in a new tab) and FDA pediatric oncology drug approvals (opens in a new tab).

Where the money has gone

Every outing, every dollar.

Since 2023, our golf and tennis outings have raised more than $425K for pediatric cancer research. In our early years, proceeds were shared between Dr. Ortiz’s research at Memorial Sloan Kettering and the Pediatric Cancer Foundation, which has funded research to eradicate childhood cancer since 1970.

Today, every dollar raised at our events goes to Dr. Ortiz’s research into rare pediatric tumors at MSK.

See our events